Neoplasms

Digestive System Diseases

All Conditions

Symptoms and General Pathology

Nutritional and Metabolic Diseases

Blood and Lymph Conditions

Immune System Diseases

Ear, Nose, and Throat Diseases

Rare Diseases

Stomach Neoplasms

Syndrome

Esophageal Neoplasms

Obesity

Irritable Bowel Syndrome

Crohn Disease

Gastrointestinal Diseases

Gastroesophageal Reflux

Colonic Polyps

Colitis

Colitis, Ulcerative

Ulcer

Gallstones

Cholelithiasis

Cholecystolithiasis

Celiac Disease

Polyps

Esophagitis

Eosinophilic Esophagitis

Barrett Esophagus

Metaplasia

Gastritis

Colitis, Microscopic

Stomach Ulcer

Duodenal Ulcer

Colitis, Lymphocytic

Stomach Diseases

Inflammatory Bowel Diseases

Intestinal Diseases

Gastroenteritis

Colonic Diseases

Esophageal Diseases

Colonic Diseases, Functional

Precancerous Conditions

Eosinophilia

Leukocyte Disorders

Hematologic Diseases

Hypersensitivity

Hypersensitivity, Immediate

Biliary Tract Diseases

Gallbladder Diseases

Calculi

Pathological Conditions, Anatomical

Esophageal Motility Disorders

Esophageal Spasm, Diffuse

Deglutition Disorders

Peptic Ulcer

Duodenal Diseases

Malabsorption Syndromes

Metabolic Diseases

Stomach Cancer

Esophageal Cancer

Eosinophilic Gastroenteritis

Hematinics

All Drugs and Chemicals

Herbal and Botanical

Liver Extracts

Cola

Participants with Eosinophilic esophagitis

Participants with Gastroesophageal Reflux Disease (GERD).

Participants with intestinal metaplasia (risk factor for esophageal cancer).

Participants with Lymphocytic/Microscopic Colitis.

Momchilo Vuyisich

This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.

This is a longitudinal, observational study whose main goal is to identify the human and microbial determinants of gastrointestinal diseases. Molecular and metadata will be collected from a large study population at multiple time points. Machine learning will be applied to all data, and models will be evaluated for development of novel diagnostic and therapeutic tools.

Systems Biology of Gastrointestinal and Related Diseases

Identification of biomarkers that indicate gastrointestinal diseases.

Identification of microbial species that indicate gastrointestinal disease.

Prediction of the efficacy of a biologic medication against IBD based on molecular data and metadata.

Development of a molecular test for C. difficile infection (CDI)

Quantification of changes observed in the microbiome post colonoscopy.

Viome

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Systems Biology of Gastrointestinal and Related Diseases	NCT05579444	Ulcerative Coli... Crohn Disease Obesity Colon Polyp Eosinophilic Es... GERD Gastro Esophage... Barrett Esophag... Esophageal Canc... Gastritis Gastric Ulcer Duodenal Ulcer Intestinal Meta... Gastric Cancer Lymphocytic Col... Microscopic Col... Celiac Sprue IBS Irritable Bowel... SIBO NAFLD Gallstone Disea...		18 Years -	Viome
Systems Biology of Gastrointestinal and Related Diseases	NCT05579444	Ulcerative Coli... Crohn Disease Obesity Colon Polyp Eosinophilic Es... GERD Gastro Esophage... Barrett Esophag... Esophageal Canc... Gastritis Gastric Ulcer Duodenal Ulcer Intestinal Meta... Gastric Cancer Lymphocytic Col... Microscopic Col... Celiac Sprue IBS Irritable Bowel... SIBO NAFLD Gallstone Disea...		18 Years -	Viome

Spots Global Cancer Trial Database for celiac sprue

Every month we try and update this database with for celiac sprue cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.